These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 23278970)

  • 1. Generic drugs in glaucoma therapy, a new reality to deal with.
    De Natale R; Gandolfi SA
    Clin Exp Ophthalmol; 2013 Aug; 41(6):622-4. PubMed ID: 23278970
    [No Abstract]   [Full Text] [Related]  

  • 2. Generic glaucoma drop bottle cap colours.
    Hallaji NAE; Trope GE
    Can J Ophthalmol; 2016 Oct; 51(5):392-393. PubMed ID: 27769334
    [No Abstract]   [Full Text] [Related]  

  • 3. Ophthalmic generics--are they really the same?
    Chambers WA
    Ophthalmology; 2012 Jun; 119(6):1095-6. PubMed ID: 22656890
    [No Abstract]   [Full Text] [Related]  

  • 4. Relative bioavailability of rifampicin in a three-drug fixed-dose combination formulation.
    Milán-Segovia RC; Domínguez-Ramírez AM; Jung-Cook H; Magaña-Aquino M; Romero-Méndez MC; Medellín-Garibay SE; Vigna-Pérez M; Romano-Moreno S
    Int J Tuberc Lung Dis; 2010 Nov; 14(11):1454-60. PubMed ID: 20937187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers to glaucoma drug delivery.
    Ghate D; Edelhauser HF
    J Glaucoma; 2008 Mar; 17(2):147-56. PubMed ID: 18344762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comments on generic antibiotics].
    Levêque D; Gourieux B
    Med Mal Infect; 2013 Jan; 43(1):35-6. PubMed ID: 23287656
    [No Abstract]   [Full Text] [Related]  

  • 7. A pharmacokinetic comparison of generic tablets containing bisoprolol with the innovator formulation in healthy volunteers.
    Jovanović D; Cusić S; Rancić D; Srnić D; Perković-Vukcević N
    J Clin Pharmacol; 2006 Oct; 46(10):1217-22. PubMed ID: 16988212
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and Safety of Glaucoma Patients' Switch from a 2% Dorzolamide/0.5% Timolol Fixed-Combination Brand-Name Drug to Its Generic Counterpart.
    Kim YI; Kim JH; Lee TY; Lee KW
    J Ocul Pharmacol Ther; 2015; 31(6):335-9. PubMed ID: 26133057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ["Critical dose" drugs. Aut-idem could cause problems here].
    MMW Fortschr Med; 2002 Jan; 144(3-4):63. PubMed ID: 11862801
    [No Abstract]   [Full Text] [Related]  

  • 10. Consideration of international generic distribution policies on patient outcomes in the United States and Germany.
    Saverno K; Gothe H; Schuessel K; Biskupiak J; Schulz M; Siebert U; Brixner D
    Pharmazie; 2014 Mar; 69(3):238-40. PubMed ID: 24716417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genericum? Which one should I choose?].
    Kovács G
    Neuropsychopharmacol Hung; 2013 Mar; 15(1):2. PubMed ID: 23542753
    [No Abstract]   [Full Text] [Related]  

  • 12. Morality play.
    Eckert C
    Science; 1996 Sep; 273(5283):1784; author reply 1784-5. PubMed ID: 8815539
    [No Abstract]   [Full Text] [Related]  

  • 13. Modeling and simulation of biopharmaceutical performance.
    Zhang X; Lionberger RA
    Clin Pharmacol Ther; 2014 May; 95(5):480-2. PubMed ID: 24747237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral drug content in products from developing countries.
    Penzak SR; Acosta EP; Turner M; Tavel JA; Masur H
    Clin Infect Dis; 2004 May; 38(9):1317-9. PubMed ID: 15127347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current issues in the pioneer versus generic drug wars.
    Safir PO
    Food Drug Law J; 1995; 50(2):335-9. PubMed ID: 10343002
    [No Abstract]   [Full Text] [Related]  

  • 16. Generic drugs for the treatment of ocular conditions: changing the treatment landscape.
    Aref AA
    Expert Rev Clin Pharmacol; 2014 Sep; 7(5):551-3. PubMed ID: 24957466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International Generic Pharmaceutical Alliance - 12th Annual Conference. Part 2.
    Kuhrt K
    IDrugs; 2009 Dec; 12(12):765-9. PubMed ID: 19943218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioequivalence evaluation of a triamterene-hydrochlorothiazide generic product: a new bioequivalence index for fixed-dose combinations.
    Hamidi M; Shahbazi MA; Azimi K
    Regul Toxicol Pharmacol; 2011 Feb; 59(1):149-56. PubMed ID: 21193005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of intraocular pressure in glaucoma subjects treated with Xalatan versus generic latanoprost.
    Egan P; Harris A; Siesky B; Abrams-Tobe L; Gerber AL; Park J; Holland S; Kim NJ; Januleviciene I
    Acta Ophthalmol; 2014 Aug; 92(5):e415-6. PubMed ID: 24373426
    [No Abstract]   [Full Text] [Related]  

  • 20. The other path for follow-ons.
    Nat Biotechnol; 2008 Jul; 26(7):715. PubMed ID: 18612272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.